ArticleEuropean journal of medical research2025
Single cell and machine learning identify type II pneumocyte-derived biomarkers HN1/OCIAD2/SFTA2 for non-small cell lung cancer prognosis and immune regulation.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gene-based lung cancer detection system through omix data and optimized convolutional neural network.Journal of computer-aided molecular design · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNon-small cell lung cancer (NSCLC) is one of the most prevalent malignancies and currently shows a poor clinical prognosis. Type II pneumocyte, as one of the main sources of cancer cells in NSCLC, is important to explore the molecular functions of its related markers for a deeper understanding of NSCLC.
methodsIn this study, NSCLC single-cell profiles and transcriptomic data were derived from Gene Expression Omnibus (GEO). Single-cell clustering was used to characterize the infiltration of type II pneumocyte and to reveal differences in the regulatory function of this cell compared to other cell subpopulations. Interactions between cellular subpopulations were clarified by CellChat. High-dimensional weighted gene co-expression network analysis (hdWGCNA) was utilized to mine modular signature genes closely relevant to type II pneumocyte in NSCLC. Differential expression analysis combined with least absolute shrinkage and selection operator (LASSO) and support vector machine recursive feature elimination (SVM-RFE), two machine learning algorithms, was used to screen key genes in NSCLC that are associated with disease progression and type II pneumocyte. The CIBERSORT and ESTIMATE algorithms were mainly used to assess the correlation between biomarkers and immune cell infiltration in NSCLC. Gene set enrichment analysis (GSEA) was used to evaluate the regulatory functions of biomarkers. CCK-8, Transwell assay, and wound healing assay were used to illustrate the regulation of biomarkers to NSCLC cell lines.
resultsSeven types of cell subpopulations were found in NSCLC samples, including macrophages, type II pneumocyte, T cell, ciliated cell, B cell, endothelial cell, and plasma cell. Among them, there is extensive cellular communication between type II pneumocyte and macrophages, mainly through ITGB2-ICAM1, HLA-DPB1-CD4, and HLA-DQB1-CD4 ligand-receptor pair binding. hdWGCNA combined with machine learning algorithms screened three key genes, HN1, OCIAD2, and SFTA2, associated with type II pneumocyte and NSCLC progression. Among them, HN1 and OCIAD2 were significantly negatively correlated with the stromal infiltration score, immunization score, and ESTIMATE score, respectively, whereas SFTA2 was significantly positively correlated with these three indicators. In vitro cellular assays indicate that HN1 and OCIAD2 are significantly upregulated in the NCI-H838 and A549 cell lines, whereas SFTA2 expression is downregulated. Furthermore, silencing HN1 significantly inhibits the proliferation, migration, and invasive capacity of NSCLC cell lines.
conclusionThis study elucidates genes in NSCLC that are highly associated with both disease progression and type II pneumocyte features as potential biomarkers of NSCLC, and predicts their potential regulatory functions as well as their impact on the immune infiltration profile of NSCLC, providing guidance for the unraveling of the immune mechanisms of NSCLC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.